A genetic test could guide the use of hormone therapy for men with recurrent prostate cancer after surgery, according to data presented at American Society for Radiation Oncology Annual Meeting.
The three-day spread of Champions League fixtures is preserved exclusively for the opening gameweek of the still relatively new league phase, with two dayers the norm moving forward. Thus, there’s a ...
Regeneron's revenue in the second quarter increased by 4% year over year to $3.68 billion. That's not phenomenal top-line ...
Despite flat overall Q2 2025 sales, Keytruda's continued strong performance in oncology supports long-term bullish prospects ...
WASHINGTON (AP) — The U.S. government starts phasing out paper checks for most programs on Tuesday. The change, which was ...
Jesse Lingard led FC Seoul to a 3-0 win over Thailand's Buriram United on Tuesday as the South Korean side picked up their first victory in this season's Asian Champions League Elite group phase at ...
Pfizer acquires Metsera to enter the booming obesity drug market with next-gen GLP-1 therapies. Find out why PFE stock is a ...
Purpose of Study: The purpose of this study is to establish the safety and potential effectiveness of investigational FT819 in participants with moderate to severe systemic lupus erythematosus (SLE) ...
TipRanks on MSN
AbbVie’s Promising Phase 1 Study on ABBV-CLS-579: A Potential Game-Changer in Cancer Treatment
Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently completed a Phase 1 clinical study titled ‘A Phase 1, ...
Following its Type A meeting with the FDA, Replimune reported that a forward pathway “has not been determined” to obtain ...
LAWRENCE, Kan. — Just more than 33 months after the initial vision was announced, the reimagined David Booth Kansas Memorial Stadium is set to officially reopen this Saturday when the Kansas Jayhawks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results